Skip to main content

252 (Pramipexole Dihydrochloride Extended-Release 0.75 mg)

Pill with imprint 252 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.75 mg. It is supplied by Par Pharmaceutical Inc.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 252

Pramipexole dihydrochloride extended-release 0.75 mg 252

Pramipexole Dihydrochloride Extended-Release

Imprint
252
Strength
0.75 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc
Inactive Ingredients
hypromelloses, corn starch, silicon dioxide, D&C Yellow No. 10, hydrogenated cottonseed oil, hydroxypropyl cellulose, magnesium stearate, mannitol, microcrystalline cellulose, titanium dioxide, magnesium silicate, soya lecithin, xanthan gum

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
10370-0252 Anchen Pharmaceuticals, Inc.
42291-0554 (Discontinued) AvKare, Inc.

Get help with Imprint Code FAQs.

Related images for "252"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.